These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20660790)

  • 1. X-linked lymphoproliferative syndromes: brothers or distant cousins?
    Filipovich AH; Zhang K; Snow AL; Marsh RA
    Blood; 2010 Nov; 116(18):3398-408. PubMed ID: 20660790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic differences between mice deficient in XIAP and SAP, two factors targeted in X-linked lymphoproliferative syndrome (XLP).
    Rumble JM; Oetjen KA; Stein PL; Schwartzberg PL; Moore BB; Duckett CS
    Cell Immunol; 2009; 259(1):82-9. PubMed ID: 19595300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral Gene Transfer Corrects Immune Abnormalities in XIAP Deficiency.
    Topal J; Panchal N; Barroeta A; Roppelt A; Mudde A; Gaspar HB; Thrasher AJ; Houghton BC; Booth C
    J Clin Immunol; 2023 Feb; 43(2):440-451. PubMed ID: 36329240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic Hematopoietic Cell Transplantation Ameliorated Asymptomatic Granulomatous and Lymphocytic Interstitial Lung Disease in a Patient With XIAP Deficiency.
    Oshima M; Matsukawa Y; Ikeda Y; Sakamoto K; Taga T; Maruo Y
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):e191-e194. PubMed ID: 38277621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: Non-EBV associated cerebral vasculitis and cerebral hemorrhage in X-linked lymphoproliferative disease.
    Li B; Chen W; Cai X; Hai Y; Pang Q; Xiang W; Zhang Z
    Front Immunol; 2024; 15():1381472. PubMed ID: 38726008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed post-COVID-19 hemophagocytic lymphohistiocytosis in patient with XIAP deficiency.
    Chen JH; Arceri T; Datta R; Sullivan KE
    Pediatr Allergy Immunol; 2023 Sep; 34(9):e14028. PubMed ID: 37747746
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency).
    Pachlopnik Schmid J; Canioni D; Moshous D; Touzot F; Mahlaoui N; Hauck F; Kanegane H; Lopez-Granados E; Mejstrikova E; Pellier I; Galicier L; Galambrun C; Barlogis V; Bordigoni P; Fourmaintraux A; Hamidou M; Dabadie A; Le Deist F; Haerynck F; Ouachée-Chardin M; Rohrlich P; Stephan JL; Lenoir C; Rigaud S; Lambert N; Milili M; Schiff C; Chapel H; Picard C; de Saint Basile G; Blanche S; Fischer A; Latour S
    Blood; 2011 Feb; 117(5):1522-9. PubMed ID: 21119115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease.
    Xiong HY; Alipanahi B; Lee LJ; Bretschneider H; Merico D; Yuen RK; Hua Y; Gueroussov S; Najafabadi HS; Hughes TR; Morris Q; Barash Y; Krainer AR; Jojic N; Scherer SW; Blencowe BJ; Frey BJ
    Science; 2015 Jan; 347(6218):1254806. PubMed ID: 25525159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new functional assay for the diagnosis of X-linked inhibitor of apoptosis (XIAP) deficiency.
    Ammann S; Elling R; Gyrd-Hansen M; Dückers G; Bredius R; Burns SO; Edgar JD; Worth A; Brandau H; Warnatz K; Zur Stadt U; Hasselblatt P; Schwarz K; Ehl S; Speckmann C
    Clin Exp Immunol; 2014 Jun; 176(3):394-400. PubMed ID: 24611904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-linked lymphoproliferative syndromes and related autosomal recessive disorders.
    Veillette A; Pérez-Quintero LA; Latour S
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):614-22. PubMed ID: 24113228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.
    Booth C; Gilmour KC; Veys P; Gennery AR; Slatter MA; Chapel H; Heath PT; Steward CG; Smith O; O'Meara A; Kerrigan H; Mahlaoui N; Cavazzana-Calvo M; Fischer A; Moshous D; Blanche S; Pachlopnik Schmid J; Latour S; de Saint-Basile G; Albert M; Notheis G; Rieber N; Strahm B; Ritterbusch H; Lankester A; Hartwig NG; Meyts I; Plebani A; Soresina A; Finocchi A; Pignata C; Cirillo E; Bonanomi S; Peters C; Kalwak K; Pasic S; Sedlacek P; Jazbec J; Kanegane H; Nichols KE; Hanson IC; Kapoor N; Haddad E; Cowan M; Choo S; Smart J; Arkwright PD; Gaspar HB
    Blood; 2011 Jan; 117(1):53-62. PubMed ID: 20926771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XIAP deficiency syndrome in humans.
    Latour S; Aguilar C
    Semin Cell Dev Biol; 2015 Mar; 39():115-23. PubMed ID: 25666262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective.
    Panchal N; Booth C; Cannons JL; Schwartzberg PL
    Front Immunol; 2018; 9():666. PubMed ID: 29670631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP.
    Tangye SG
    J Clin Immunol; 2014 Oct; 34(7):772-9. PubMed ID: 25085526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoma and cerebral vasculitis in association with X-linked lymphoproliferative disease.
    Zhu J; Zhang Y; Zhen ZJ; Chen Y; Wang J; Cai RQ; Sun XF
    Chin J Cancer; 2013 Dec; 32(12):673-7. PubMed ID: 23816555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM.
    Sayos J; Wu C; Morra M; Wang N; Zhang X; Allen D; van Schaik S; Notarangelo L; Geha R; Roncarolo MG; Oettgen H; De Vries JE; Aversa G; Terhorst C
    Nature; 1998 Oct; 395(6701):462-9. PubMed ID: 9774102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene.
    Coffey AJ; Brooksbank RA; Brandau O; Oohashi T; Howell GR; Bye JM; Cahn AP; Durham J; Heath P; Wray P; Pavitt R; Wilkinson J; Leversha M; Huckle E; Shaw-Smith CJ; Dunham A; Rhodes S; Schuster V; Porta G; Yin L; Serafini P; Sylla B; Zollo M; Franco B; Bolino A; Seri M; Lanyi A; Davis JR; Webster D; Harris A; Lenoir G; de St Basile G; Jones A; Behloradsky BH; Achatz H; Murken J; Fassler R; Sumegi J; Romeo G; Vaudin M; Ross MT; Meindl A; Bentley DR
    Nat Genet; 1998 Oct; 20(2):129-35. PubMed ID: 9771704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked lymphoproliferative disease: twenty-five years after the discovery.
    Seemayer TA; Gross TG; Egeler RM; Pirruccello SJ; Davis JR; Kelly CM; Okano M; Lanyi A; Sumegi J
    Pediatr Res; 1995 Oct; 38(4):471-8. PubMed ID: 8559596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine Storm Syndromes Associated with Epstein-Barr Virus.
    Verbist K; Nichols KE
    Adv Exp Med Biol; 2024; 1448():227-248. PubMed ID: 39117818
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.